Hepatology communicationsHumansRifaximinHepatic EncephalopathyMaleFemale
Rifaximin reduces rehospitalization risk in patients with cirrhosis and overt hepatic encephalopathy.
Arun B Jesudian, Patrick Gagnon-Sanschagrin, Rebecca Bungay, Kaitlyn Easson, Remi Bellefleur, Annie Guérin, Shweta Kiran Shah, Olamide Olujohungbe
Published: 202610.1097/HC9.0000000000000874
Abstract
BACKGROUND: Rifaximin treatment is associated with reduced rates of overt hepatic encephalopathy (OHE) hospitalization relative to lactulose alone. This real-world study evaluated the impact of treatment on rehospitalizations following an initial OHE…
Preview only. Read the full abstract at the source